lufotrelvir pf antivir drug develop pfizer act cl proteas inhibitor prodrug phosphat group cleav vivo yield activ agent pf lufotrelvir human clinic trial treatment covid show good activ covid includ sever variant strain unlik relat drug nirmatrelvir oral activ must administ intraven infus less favour candid clinic develop overal antiinfect drug articl stub help wikipedia expand